PremiumIONS

Unusual insider trade at Ionis: director increased holdings by 500%

Dr. Michael R. Hayden, a world-renowned scientist in genetic medicine and a director at Ionis, invested $1.06 million of his private funds and increased his holdings in the company by 500%.

By the SpyStocks desk · 3w ago · 4 min read

Related Stories

Major move at Somnigroup International: CEO buys shares for almost $2 million one day after major deal completion

PremiumInsidersSGI8h ago3 min read

Will Pfizer do a Moderna for investors?

PremiumInsidersPFE1d ago4 min read

Intriguing activity in Madison Air

PremiumInsidersMAIR1d ago3 min read